Chen H Chow

17 posts

Chen H Chow

Chen H Chow

@Chenhoe

Katılım Nisan 2009
162 Takip Edilen18 Takipçiler
Chen H Chow
Chen H Chow@Chenhoe·
My pc is so slow, uploading photos to share is taking longer than doing consults.
English
0
0
0
0
Chen H Chow
Chen H Chow@Chenhoe·
About 15-20% of severe AS are either paradoxical LFLG or NFLG with comparable post TAVR outcome as high gradient severe AS. If we don’t look, we don’t find. ahajournals.org/doi/10.1161/CI…
Chen H Chow tweet media
English
0
0
1
0
Chen H Chow retweetledi
AHAKansas
AHAKansas@AHAKansas·
Makayln we're thinking of you! ❤️ Today, we're sending positive vibes, healing thoughts and prayers to CHD Warrior Makalyn, her family and her medical team as she prepares for the 3rd stage of her Fontan surgery.
AHAKansas tweet media
English
1
2
3
0
Chen H Chow
Chen H Chow@Chenhoe·
Is it believable?
English
0
0
0
0
Chen H Chow retweetledi
The ISHLT
The ISHLT@ISHLT·
#ISHLT leaders have decided to cancel #ISHLT2020. Our top priority is the health and safety of our attendees, staff, partners and vendors. We will keep you updated on refunds and next steps. Please follow us here and check online for updates. ishlt.org/publications-r…
English
2
38
61
0
Rory O' Hanlon
Rory O' Hanlon@ohanloncmr·
Doesn’t get any more pathognomonic than this does it ! #Whycmr
Rory O' Hanlon tweet media
English
5
22
41
0
Chen H Chow
Chen H Chow@Chenhoe·
@BrettSperryMD IABP is probably better (compared to Impella) with restrictive cardiomyopathy anyway.
English
0
0
1
0
Brett Sperry, MD
Brett Sperry, MD@BrettSperryMD·
Not classic to have such an improvement with a restrictive cardiomyopathy, but may happen particularly in those with low EF. #PowerOfThePump
English
2
0
8
0
Brett Sperry, MD
Brett Sperry, MD@BrettSperryMD·
Another anecdote: patient with end stage ATTR amyloidosis and EF 30%. Cardiac index 1.8 and creatinine 2+ for the past year. IABP placed and CI marginally improves to 2.0 but creatinine 2.3➡️2.1➡️1.8➡️1.5.
Michelle Kittleson MD PhD@MKIttlesonMD

#TipsForNewDocs- quiz! Pt with HF: dobutamine 5 mcg/kg/min, milrinone 0.375 mcg/kg/min, Lasix 20 mg/h. Day 1 HR 102 MAP 55 RA 14, PA 56/25, PCWP 28, CI 1.6 3L urine. Cr 2.4 Day 2 HR 98 MAP 60 RA 10, PA 36/16, PCWP 18, CI 2.4 7L urine. Cr 1.8 What happened on day 2?

English
2
2
8
0
Eiran Gorodeski, MD, MPH
Eiran Gorodeski, MD, MPH@EiranGorodeski·
Clinical assessment of hemodynamics is entirely unreliable, across training levels. @BurkhoffMd #HFSA2019 Imvasive monitoring with swan is absolutely essential.
Eiran Gorodeski, MD, MPH tweet media
English
3
4
24
0
Ahmad Masri
Ahmad Masri@MasriAhmadMD·
A much needed study on T1 mapping on #whycmr in ARVD. I really like T1, but I also dont think such a small difference in T1 (1067 vs 1038 ms on 1.5T) is clinically meaningful irrespective of p value. What do you say #whycmr peeps? sciencedirect.com/science/articl…
Ahmad Masri tweet mediaAhmad Masri tweet mediaAhmad Masri tweet media
English
6
4
19
0
Chen H Chow
Chen H Chow@Chenhoe·
@gcfmd Looking more like a new “statin” but for HF.
English
0
0
1
0
Gregg Fonarow MD
Gregg Fonarow MD@gcfmd·
The canagliflozin group had a lower risk of CV death, MI, or stroke (HR 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for HF (HR, 0.61; 95% CI, 0.47 to 0.80; P<0.001) Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy | NEJM nejm.org/doi/full/10.10…
English
3
21
64
0
Michael Nassif
Michael Nassif@MichaelNassifMD·
@boback @gcfmd The benefits have nothing to do with glucose lowering. The question of whether it will be effective in pre diabetics and non diabetics is the multibillion dollar question though, and it will be answered very soon.
English
2
0
5
0
Chen H Chow retweetledi
Nir Uriel, MD MSc
Nir Uriel, MD MSc@NirUrielMD·
Exciting time to be here in Astana, Kazakhstan. First-in-man experience of wireless CF-LVAD implant from @leviticuscardio. NO Driveline! Uses internal coils capable of holding charge for 8 hours. Read about it now in @TheJHLT jhltonline.org/article/S1053-…
leviticuscardio@leviticuscardio

Prof. Yuriy Pya, MD, PhD, and his global team from the Czech Republic, Israel, Italy and the U.S.A fit the world's FIH Leviticus FiVAD™. The future of Chronic Heart Failure treatment?

Kazakhstan 🇰🇿 English
5
39
109
0